Evaluating a service model for management of hypertension and diabetes among low and middle- income patients enrolled on M-TIBA in Kenya

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

PACTR

Registry ID

PACTR202003783697033

Enrollment

406

Registered

2020-03-30

Start date

2020-01-13

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Circulatory System Nutritional, Metabolic, Endocrine

Interventions

BP device plus behavior intervention A

BP device plus behavior intervention B

BP device no behavior intervention C

Glucometer device plus behavior intervention

Glucometer device but no behavior intervention

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients with a new diagnosis of essential HTN or diagnosed with type 2 diabetes 2. Patients known to have essential HTN or with diabetes who are already receiving medication. 3. HTN- or diabetic patients receiving treatment provided by the recruiting site 4. Adult (> 18 years old) 5. Ownership of a phone 6. Patients paying out of pocket and willing to be enrolled on M-TIBA

Exclusion criteria

Exclusion criteria: 1. Patients with (suspected) secondary HTN, as described by local guidelines. This diagnosis is at discretion of the treating physician 2. HTN-patients requiring treatment (secondary, tertiary HTN care) not provided by the recruiting site 3. Patients unwilling or who refuse to give informed consent 4. Arm circumference greater than or less than the 22-42 cm for which the used cuffs is validated 5. Failure to obtain valid BP-values (e.g. cardiac arrhythmias) 6. Pregnancy 7. Patients who are judged to be unsuitable for receipt of mobile HTN or diabetes care by the treating physicians (for instance, patients with life-threatening diseases, dementia, and illiterate patients). 8. Patients who have had an acute cardiovascular event in the previous 3 months.

Design outcomes

Primary

Measure	Time frame
Mean change in systolic blood pressure;Mean change in diastolic blood pressure ;Mean change in fasting blood sugar/HbA1c<7%	—

Secondary

Measure	Time frame
Frequency of measuring blood pressure;Frequency of measuring blood sugar;Cost-effectiveness of the intervention;Acceptability of the intervention by patients	—

Countries

Kenya

Contacts

Public ContactGershim Asiki

Research Scientist African Population and Health Research Center

gasiki@aphrc.org+254204001000

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026